期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基因修饰的间充质干细胞临床研究进展 被引量：3

Clinical Research Progress of Genetically Modified Mesenchymal Stem Cells
下载PDF
导出
摘要 基因修饰的间充质干细胞(MSC)可有效地提高移植后细胞存活率,使细胞有效聚集于损伤部位。通过不断优化干细胞和载体选择,有效导入特定基因到MSC内,表达特定蛋白,可用于治疗获得性和遗传性疾病。我们就相关进展及问题做简要阐述,以期为基因修饰的MSC临床应用研究提供借鉴。 Genetically modified mesenchymal stem cells（MSC） can effectively increase the survival of transplant？ed cells, and promote therapeutic cells aggregation at the site of injury. Through effective introduction of specific genes by continuous optimizing the selection of stem cells and vectors, MSC can express specific proteins, and can be used for the treatment of acquired or inherited diseases. In this paper, we elaborated the progress and is？sues in order to provide reference for clinical application of mesenchymal stem cells genetically modified.
作者 孙辉 孙涛
机构地区 海军总医院消化内科
出处 《生物技术通讯》 CAS 2014年第6期867-870,共4页 Letters in Biotechnology
关键词 基因修饰 间充质干细胞 临床治疗 genetically modification mesenchymal stem cells clinical treatment
分类号 R25 [医药卫生—中医内科学] R45 [医药卫生—治疗学]
  • 相关文献

参考文献24

  • 1Friedenstein A J, Piatetzky-Shapiro I I Petrakova K V. Osteo-genesis in transplants of bone marrow cells[J]. Embryol Exp Morphol, 1966,16(3):381-390.
  • 2Wakitani S, Nawata M, Tensho K, et al. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case re- ports involving nine defects in five knees[J]. Tissue Eng Re- gen Med, 2007,1(1):74-79.
  • 3Henkens T, Papeleu P, Elaut G, et al. Trichostatin A, a criti- cal factor in maintaining the functional differentiation of pri- mary cultured rat hepatocytes[J]. Toxicol Appl Pharmacol, 2007,218( 1):64-71.
  • 4Snykers S, Vanhaecke T, De Becker A, et al. Chromatin re- modeling agent trichostatin A: a key-factor in the hepatic dif- ferentiation of human mesenchymal stem cells derived of adult bone marrow[J]. BMC Dev Biol, 2007,7:24.
  • 5Shahbazian M D, Grunstein M. Functions of site-specific his- tone acetylation and deacetylation[J]. Annu Rev Biochem, 2007,76:75-100.
  • 6Li Y, Zhang R, Qiao H, et al. Generation of insulin-produc- ing cells from PDX-1 genemodified human mesenchymal stem cells[J]. J Cell Physiol, 2007,211(1):36-44.
  • 7Cheng Z, Ou L, Zhou X, et al. Targeted migration of mesen- chymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance[J]. Mol Ther, 2008, 16(3):571-579.
  • 8Zhang D, Fan G C, Zhou X, et al. Over-expression of CX- CR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium[J]. Mol Cell Cardiol, 2008,44(2):281- 292.
  • 9Noiseux N, Gnecchi M, Lopez-llasaca M, et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation[J]. Mol Ther, 2006,14(6):840- 850.
  • 10Kim S S, Yoo S W, Park T S, et al. Neural induction with neurogeninl increases the therapeutic effects of mesenehymal stem cells in the ischemic brain[J]. Stem Ceils, 2008,26(9): 2217-2228.

同被引文献26

  • 1Benhar M. Nitric oxide and the thioredoxin system: a complex interplay in redox regulation[J]. Biochim Biophys Acta, 2015,1850(12):2476-2484.
  • 2Sharma R R, Pollock K, Hubel A, et al. Mesenchymal stem or stromal ceils: a review of clinical applications and manufacturing practices[J]. Transfusion, 2014,54(5):1418-1437.
  • 3Mahmood D F, Abderrazak A, E1 Hadri K, et al. The thioredoxin system as a therapeutic target in human health and disease[J]. Antioxid Redox Signal 2013,19(11):1266-1303.
  • 4Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006,8(4):315-317.
  • 5Byun H S, Cho E W, Kim J S, et al. Thioredoxin overexpression in HT-I080 ceils induced cellular senescence and sensitization to gamma radiation[J]. FEBS Lett, 2005,579(19):40554062.
  • 6Hwang C Y, Ryu Y S, Chung M S, et al. Thioredoxin modulates activator protein I(AP-1) activity and p27Kipl degradation through direct interaction with Jabl[J]. Oncogene, 2004,23 (55):8868-8875.
  • 7Chen X, Zhao Y, Wu X, et al. Enhanced expression of single immunoglobulin 1L-1 recepter-related molecule ameliorates LPS-induced acute lung injury in mice [J]. Shock, 2011, 35 (2) : 198-204.
  • 8He HL, Liu L, Chen QH, et al. MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS[J]. J Cell Physiol, 2015,230 (3) :691-701.
  • 9Chen C, Zhang F, Zhang Z, et al. TLR4 slgnaling-inducedheme oxygenase upregulation in the acute lung injury: role in hemorrhagic shock and two-hit induced lung inflammation [J].Mol Biol Rep, 2013, 40 (2): 1167-1172.
  • 10Carroll SH, Wigner NA, Kulkarni N, et al. A2B adenosine receptor promotes mesenehymal stem cell differentiation to osteoblasts and bone formation in vivo[J]. J Biol Chem, 2012, 287(19) :15718-15727.

引证文献3

二级引证文献1

生物技术通讯
2014年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部